<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">37161</article-id><article-id pub-id-type="doi">10.7554/eLife.37161</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-45289"><name><surname>Fanning</surname><given-names>Sean W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9428-0060</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50859"><name><surname>Jeselsohn</surname><given-names>Rinath</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111025"><name><surname>Dharmarajan</surname><given-names>Venkatasubramanian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111026"><name><surname>Mayne</surname><given-names>Christopher G</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8905-6569</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111027"><name><surname>Karimi</surname><given-names>Mostafa</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111028"><name><surname>Buchwalter</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-11787"><name><surname>Houtman</surname><given-names>René</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-45970"><name><surname>Toy</surname><given-names>Weiyi</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111029"><name><surname>Fowler</surname><given-names>Colin E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125755"><name><surname>Han</surname><given-names>Ross</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126632"><name><surname>Lainé</surname><given-names>Muriel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45967"><name><surname>Carlson</surname><given-names>Kathryn E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45968"><name><surname>Martin</surname><given-names>Teresa A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9738"><name><surname>Nowak</surname><given-names>Jason</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9730"><name><surname>Nwachukwu</surname><given-names>Jerome C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4313-9187</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3584"><name><surname>Hosfield</surname><given-names>David J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7169"><name><surname>Chandarlapaty</surname><given-names>Sarat</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4532-8053</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8896"><name><surname>Tajkhorshid</surname><given-names>Emad</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8434-1010</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9637"><name><surname>Nettles</surname><given-names>Kendall W</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11788"><name><surname>Griffin</surname><given-names>Patrick R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3589"><name><surname>Shen</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3664"><name><surname>Katzenellenbogen</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3615"><name><surname>Brown</surname><given-names>Myles</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8213-1658</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3588"><name><surname>Greene</surname><given-names>Geoffrey L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6894-8728</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Ben May Department for Cancer Research</institution>, <institution>University of Chicago</institution>, <addr-line><named-content content-type="city">Chicago</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Center for Functional Cancer Epigenetics</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Molecular Medicine</institution>, <institution>The Scripps Research Institute</institution>, <addr-line><named-content content-type="city">Jupiter</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Chemistry</institution>, <institution>University of Illinois at Urbana-Champaign</institution>, <addr-line><named-content content-type="city">Urbana</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Electrical and Computer Engineering, TEES-AgriLife Center for Bioinformatics and Genomic Systems Engineering</institution>, <institution>Texas A&amp;M University</institution>, <addr-line><named-content content-type="city">College Station</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Center for Functional Epigenetics</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Nuclear Receptor Group</institution>, <institution>PamGene International</institution>, <addr-line><named-content content-type="city">Den Bosch</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff8"><institution content-type="dept">Human Oncology and Pathogenesis Program</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Illinois at Urbana-Champaign</institution>, <addr-line><named-content content-type="city">Urbana</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1025"><name><surname>Sawyers</surname><given-names>Charles L</given-names></name><role>Reviewing editor</role><aff><institution>Memorial Sloan-Kettering Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ggreene@uchicago.edu</email> (GG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>11</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e37161</elocation-id><history><date date-type="received"><day>31</day><month>03</month><year>2018</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Fanning et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Fanning et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-37161-v1.pdf"/><abstract><p>Acquired resistance to endocrine therapy remains a significant clinical burden for breast cancer patients. Somatic mutations in the <italic>ESR1</italic> (estrogen receptor alpha (ERα)) gene ligand-binding domain (LBD) represent a recognized mechanism of acquired resistance. Antiestrogens with improved efficacy versus tamoxifen might overcome the resistant phenotype in ER+ breast cancers. Bazedoxifene (BZA) is a potent antiestrogen that is clinically approved for use in hormone replacement therapies. We found that BZA possesses improved inhibitory potency against the Y537S and D538G ERα mutants compared to tamoxifen and has additional inhibitory activity in combination with the CDK4/6 inhibitor palbociclib. In addition, comprehensive biophysical and structural biology studies show BZA's selective estrogen receptor degrading (SERD) properties that override the stabilizing effects of the Y537S and D538G ERα mutations.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009634</institution-id><institution>Susan G. Komen</institution></institution-wrap></funding-source><award-id>PDF14301382</award-id><principal-award-recipient><name><surname>Fanning</surname><given-names>Sean W</given-names></name><name><surname>Greene</surname><given-names>Geoffrey L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CCSG P30 CA08748</award-id><principal-award-recipient><name><surname>Chandarlapaty</surname><given-names>Sarat</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001006</institution-id><institution>Breast Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>BCRF-17-083</award-id><principal-award-recipient><name><surname>Katzenellenbogen</surname><given-names>John A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01CA204999</award-id><principal-award-recipient><name><surname>Chandarlapaty</surname><given-names>Sarat</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>Breakthrough Award W81XWH-14-1-0360</award-id><principal-award-recipient><name><surname>Fanning</surname><given-names>Sean W</given-names></name><name><surname>Toy</surname><given-names>Weiyi</given-names></name><name><surname>Fowler</surname><given-names>Colin E</given-names></name><name><surname>Chandarlapaty</surname><given-names>Sarat</given-names></name><name><surname>Greene</surname><given-names>Geoffrey L</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM124952</award-id><principal-award-recipient><name><surname>Shen</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>CCF-1546278</award-id><principal-award-recipient><name><surname>Shen</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Gilles Buchwalter, Employee and shareholder of Celgene.</p></fn><fn fn-type="conflict" id="conf3"><p>René Houtman, Employee of PamGene International.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>X-ray crystallographic data were deposited in the PDB under the accession code 4XI3.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Fanning SW</collab><collab>Mayne CG</collab><collab>Toy W</collab><collab>Carlson K</collab><collab>Green B</collab><collab>Nowak J</collab><collab>Walte</collab><collab>R</collab><collab>Panchamukhi S</collab><collab>Tajkhorshid E</collab><collab>Nettles KW</collab><collab>Chandaralapaty S</collab><collab>Katznellenbogen JA</collab><collab>Greene GL</collab></person-group><year iso-8601-date="2015">2015</year><source>Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4xi3">https://www.rcsb.org/structure/4xi3</ext-link><comment>Protein Data Bank, 4XI3</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-37161-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>